cladribine has been researched along with Opportunistic Infections in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (52.38) | 18.2507 |
| 2000's | 9 (42.86) | 29.6817 |
| 2010's | 1 (4.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ravandi, F; Thompson, PA | 1 |
| Błoński, JZ; Dwilewicz-Trojaczek, J; Góra-Tybor, J; Kasznicki, M; Robak, T; Stella-Hołowiecka, B; Wołowiec, D | 1 |
| André, M; Costantini, S; Ferrant, A; Francart, J; Lambert, C; Layios, N; Michaux, L; Robert, A; Sonet, A; Van Den Neste, E | 1 |
| Blonski, JZ; Gora-Tybor, J; Kasznicki, M; Robak, T; Smolewski, P; Urbanska-Rys, H | 1 |
| Anavi, BL; Panchovska, MS; Solakov, PT; Spasov, EA; Tokmakova, KP | 1 |
| Dinçol, G; Kahraman, R | 1 |
| Kobayashi, M; Mizoroki, F; Nagasaki, E; Nozato, A; Okawa, Y; Shimada, T | 1 |
| Graber, P; Sendi, P; Wolf, A; Zimmerli, W | 1 |
| Heldal, D; Juliusson, G; Lenkei, R; Liliemark, J; Tjønnfjord, G | 1 |
| Betticher, DC; Fey, MF; Gratwohl, A; Hess, U; Jenzer, H; Lohri, A; Pagani, O; Pugin, P; Tobler, A; von Rohr, A | 1 |
| Drake, D; Fitzgerald-Bocarsly, P; Hoffman, M; Janson, D; Rai, KR; Sawitsky, A; Shah, K; Shodell, M; Siegal, FP | 1 |
| Hurria, A; Kuzel, TM; Rademaker, AW; Roenigk, HH; Rosen, ST; Samuelson, E; Tallman, MS | 1 |
| Juliusson, G; Liliemark, J | 2 |
| Juliusson, G | 1 |
| Bashford, J; Bunce, I; Dodds, A; Eliadis, P; Firkin, F; Frost, T; Goldstein, D; Grigg, A; Kelly, C; Kimber, R; Lee, N; Lowenthal, R; Moore, D; Morton, J; Mulligan, S; Parkin, J; Rentoul, A; Rodwell, R; Rooney, K; Stone, J; Taylor, K; Wright, S | 1 |
| Betticher, DC; Cerny, T; Egger, T; Fey, MF; Hess, U; Hsu Schmitz, SF; Pugin, P; Ratschiller, D; Stalder, M; von Rohr, A | 1 |
| Betticher, DC; Cavalli, F; Cerny, T; Egger, T; Fey, MF; Herrmann, R; Kroner, T; Ratschiller, D; Schmitz, SF; Sonderegger, T; von Rohr, A; Zulian, GB | 1 |
| Bastie, JN; Castaigne, S; Cazals-Hatem, D; D'Agay, MF; Dabout, D; Daniel, MT; Degos, L; Dombret, H; Flandrin, G; Glaisner, S; Noel-Walter, MP; Poisson, D; Rabian, C | 1 |
| Celsing, F; Cristiansen, I; Delannoy, A; Johnson, SA; Juliusson, G; Karlsson, K; Kimby, E; Lärfars, G; Liliemark, J; Luthman, M; Nilsson, G; Porwit, A; Strömberg, M; Sundström, G; Tidefelt, U; Wallvik, J | 1 |
| Chizuka, A; Kami, M; Kanda, Y; Kunitoh, H; Makimoto, A; Matsubara, H; Mineishi, S; Nakai, K; Niiya, H; Ohnishi, M; Saito, T; Takaue, Y; Takeuchi, T; Tanosaki, R; Tobinai, K | 1 |
1 review(s) available for cladribine and Opportunistic Infections
| Article | Year |
|---|---|
How I manage patients with hairy cell leukaemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cladribine; Diagnosis, Differential; Humans; Immunologic Factors; Interferon-alpha; Leukemia, Hairy Cell; Mutation; Opportunistic Infections; Pentostatin; Proto-Oncogene Proteins B-raf; Purine Nucleosides; Rituximab; Social Support; Splenectomy; Treatment Outcome | 2017 |
9 trial(s) available for cladribine and Opportunistic Infections
| Article | Year |
|---|---|
Cladribine combined with cyclophosphamide is highly effective in the treatment of chronic lymphocytic leukemia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cyclophosphamide; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoplasm, Residual; Neutropenia; Opportunistic Infections; Remission Induction; Survival Analysis; Thrombocytopenia; Treatment Outcome | 2002 |
High incidence of complications after 2-chloro-2'-deoxyadenosine combined with cyclophosphamide in patients with advanced lymphoproliferative malignancies.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cyclophosphamide; Female; Humans; Leukopenia; Lymphoproliferative Disorders; Male; Middle Aged; Neoplasms, Second Primary; Opportunistic Infections; Survival Analysis | 2004 |
Rituximab followed by cladribine in the treatment of heavily pretreated patients with indolent lymphoid malignancies.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Female; Hematologic Diseases; Humans; Lymphoproliferative Disorders; Male; Middle Aged; Opportunistic Infections; Remission Induction; Rituximab; Salvage Therapy; Survival Analysis | 2004 |
Low-dose cladribine for symptomatic hairy cell leukaemia.
Topics: Adult; Aged; Cladribine; Dose-Response Relationship, Drug; Hemoglobins; Humans; Leukemia, Hairy Cell; Lymphocyte Count; Middle Aged; Opportunistic Infections; Platelet Count | 1995 |
High incidence of infections after 2-chlorodeoxyadenosine (2-CDA) therapy in patients with malignant lymphomas and chronic and acute leukaemias.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Bone Marrow Diseases; Chronic Disease; Cladribine; Female; Humans; Immunocompromised Host; Incidence; Leukemia; Lymphoma; Male; Middle Aged; Opportunistic Infections; Prospective Studies; Treatment Outcome | 1994 |
Phase II trial of 2-chlorodeoxyadenosine for the treatment of cutaneous T-cell lymphoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Bone Marrow Diseases; Cladribine; Female; Humans; Male; Middle Aged; Mycosis Fungoides; Opportunistic Infections; Sezary Syndrome; Skin Neoplasms; Treatment Outcome | 1996 |
Cladribine (2-CDA) given as subcutaneous bolus injections is active in pretreated Waldenström's macroglobulinaemia. Swiss Group for Clinical Cancer Research (SAKK).
Topics: Adult; Aged; Aged, 80 and over; Cladribine; Female; Humans; Immunosuppressive Agents; Injections, Intradermal; Male; Middle Aged; Neutropenia; Opportunistic Infections; Thrombocytopenia; Treatment Outcome; Waldenstrom Macroglobulinemia | 1997 |
Fewer infections, but maintained antitumor activity with lower-dose versus standard-dose cladribine in pretreated low-grade non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Drug Administration Schedule; Female; Humans; Immunocompromised Host; Logistic Models; Lymphoma, Non-Hodgkin; Male; Middle Aged; Opportunistic Infections; Prospective Studies; Remission Induction; Risk; Statistics, Nonparametric; Survival Analysis | 1998 |
Oral cladribine for B-cell chronic lymphocytic leukaemia: report of a phase II trial with a 3-d, 3-weekly schedule in untreated and pretreated patients, and a long-term follow-up of 126 previously untreated patients.
Topics: Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Follow-Up Studies; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Neoplasm, Residual; Opportunistic Infections; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome | 2002 |
11 other study(ies) available for cladribine and Opportunistic Infections
| Article | Year |
|---|---|
Wrist tuberculosis in cladribine--induced remission of hairy cell leukosis.
Topics: Antitubercular Agents; Biopsy, Needle; Cladribine; Humans; Immunohistochemistry; Leukemia, Hairy Cell; Male; Middle Aged; Opportunistic Infections; Remission Induction; Risk Assessment; Tuberculosis, Osteoarticular; Wrist Joint | 2000 |
Cryptococcus neoformans meningitis in a patient with hairy cell leukemia.
Topics: Adult; Antineoplastic Agents; Cladribine; Cryptococcus neoformans; Humans; Leukemia, Hairy Cell; Lymphopenia; Male; Meningitis, Cryptococcal; Opportunistic Infections; Treatment Outcome | 2006 |
[Pulmonary cryptococcosis occurring 6 months after cladribine therapy for relapsed follicular lymphoma].
Topics: Antineoplastic Agents; Bone Marrow; Cladribine; Cryptococcosis; Humans; Lung Diseases, Fungal; Lymphoma, Follicular; Male; Middle Aged; Opportunistic Infections; Tomography, X-Ray Computed | 2006 |
Multiple opportunistic infections after high-dose steroid therapy for giant cell arteritis in a patient previously treated with a purine analog.
Topics: Aged; Amphotericin B; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Cladribine; Cytomegalovirus; Dexamethasone; Esophagitis; Female; Giant Cell Arteritis; Herpes Simplex; Humans; Klebsiella Infections; Klebsiella pneumoniae; Leukemia, Hairy Cell; Methylprednisolone; Opportunistic Infections; Pneumocystis carinii; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
Impaired interferon alpha response in hairy cell leukemia is corrected by therapy with 2-chloro-2'-deoxyadenosine: implications for susceptibility to opportunistic infections.
Topics: Adult; Aged; Cladribine; Disease Susceptibility; Female; Humans; Interferon-alpha; Leukemia, Hairy Cell; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Middle Aged; Opportunistic Infections; Remission Induction; Splenectomy; T-Lymphocyte Subsets | 1994 |
Long-term survival following cladribine (2-chlorodeoxyadenosine) therapy in previously treated patients with chronic lymphocytic leukemia.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cell Count; Cladribine; Combined Modality Therapy; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Opportunistic Infections; Remission Induction; Retreatment; Survival Rate; Treatment Outcome; Vidarabine | 1996 |
Immediate or delayed therapy with 2-CdA for hairy cell leukemia in Jehova's Witness?
Topics: Anemia; Antineoplastic Agents; Blood Transfusion; Christianity; Cladribine; Drug Administration Schedule; Humans; Immunosuppressive Agents; Interferon-alpha; Leukemia, Hairy Cell; Opportunistic Infections; Treatment Refusal | 1996 |
High response rates with short infusional 2-chlorodeoxyadenosine in de novo and relapsed low-grade lymphoma. Australian and New Zealand Lymphoma Study Group.
Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukopenia; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Opportunistic Infections; Recurrence; Survival Analysis; Thrombocytopenia; Treatment Outcome | 1996 |
Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatment.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Marrow; CD4 Lymphocyte Count; Cladribine; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Female; Follow-Up Studies; Humans; Infections; Interferon-alpha; Leukemia, Hairy Cell; Male; Middle Aged; Neoplasm, Residual; Neoplasms, Second Primary; Opportunistic Infections; Pentostatin; Remission Induction; Splenectomy; Survival Rate | 1999 |
Suspected delayed immune recovery against cytomegalovirus after reduced-intensity stem cell transplantation using anti-thymocyte globulin.
Topics: Adolescent; Adult; Aged; Antigens, Viral; Antilymphocyte Serum; Busulfan; Cladribine; Cohort Studies; Cytomegalovirus; Cytomegalovirus Infections; Female; Hematopoietic Stem Cell Transplantation; Humans; Immune System; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Male; Middle Aged; Opportunistic Infections; Retrospective Studies; Treatment Outcome | 2002 |
Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2'-deoxyadenosine (CdA): relation to opportunistic infections.
Topics: 2-Chloroadenosine; Antineoplastic Agents; Candidiasis; Cladribine; Cytomegalovirus Infections; Deoxyadenosines; Humans; Immunophenotyping; Leukemia, Hairy Cell; Leukopenia; Lymphocytes; Monocytes; Neutrophils; Opportunistic Infections; Remission Induction; Thrombocytopenia | 1992 |